Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma

Cancer Science

Volumn 101, Issue 4, 2010, Pages 1038-1044

  Sakamoto, Naoya ^a   Oue, Naohide ^a   Noguchi, Tsuyoshi ^b   Sentani, Kazuhiro ^a   Anami, Katsuhiro ^a   Sanada, Yuichi ^c   Yoshida, Kazuhiro ^c   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c Graduate School of Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS1 PROTEIN; ADAMTS16 PROTEIN; UNCLASSIFIED DRUG; ADAM PROTEIN; ADAMTS16 PROTEIN, HUMAN;

AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERIAL ANALYSIS OF GENE EXPRESSION; UPREGULATION; WESTERN BLOTTING; ESOPHAGUS TUMOR; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADAM PROTEINS; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 77957255169     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01477.x     Document Type: Article

References (30)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
2. Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 1992; 69: 1088-93.
3. Tamoto E, Tada M, Murakawa K et al. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res 2004; 10: 3629-38.
4. Buckhaults P, Rago C, St Croix B et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001; 61: 6996-7001.
5. Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 2004; 95: 385-92.
6. Lu J, Liu Z, Xiong M et al. Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 2001; 91: 288-94.
7. Kan T, Shimada Y, Sato F et al. Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma. Ann Surg Oncol 2004; 11: 1070-8.
8. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995; 270: 484-7.
9. Oue N, Hamai Y, Mitani Y et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 2004; 64: 2397-405.
10. Aung PP, Oue N, Mitani Y et al. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 2006; 25: 2546-57.
11. Mitani Y, Oue N, Matsumura S et al. Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. Oncogene 2007; 26: 4383-93.
12. Oue N, Sentani K, Noguchi T et al. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 2009; 125: 2383-92.
13. van Baal JW, Milana F, Rygiel AM et al. A comparative analysis by SAGE of gene expression profiles of esophageal adenocarcinoma and esophageal squamous cell carcinoma. Cell Oncol 2008; 30: 63-75.
14. van Baal JW, Milano F, Rygiel AM et al. A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology 2005; 129: 1274-81.
15. Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci 2007; 98: 621-8.
16. Rodriguez-Lopez J, Pombo-Suarez M, Loughlin J et al. Association of a nsSNP in ADAMTS14 to some osteoarthritis phenotypes. Osteoarthritis Cartilage 2009; 17: 321-7.
17. Sobin LH, Wittekind CH, eds. TNM Classification of Malignant Tumors, 6th edn. New York: Wiley-Liss, 2002; 60-4.
18. Kondo T, Oue N, Yoshida K et al. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 2004; 64: 523-9.
19. Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T. Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 1993; 119: 441-9.
20. Yasui W, Sano T, Nishimura K et al. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression. Int J Cancer 1993; 54: 49-52.
21. Alley MC, Scudiero DA, Monks A et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601.
22. Cal S, Obaya AJ, Llamazares M, Garabaya C, Quesada V, Lopez-Otin C. Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene 2002; 283: 49-62.
23. Mino-Miyagawa N, Kimura Y, Hamamoto K. Tumor-antigen 4. Its immunohistochemical distribution and tissue and serum concentrations in squamous cell carcinoma of the lung and esophagus. Cancer 1990; 66: 1505-12.
24. Sugimachi K, Kitamura M, Matsuda H, Okudaira Y. Tumor antigen TA-4: an aid in detecting post-operative recurrences of esophageal carcinoma. Dis Markers 1987; 5: 67-73.
25. Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol 2003; 4: 216.
26. Ashida A, Boku N, Aoyagi K et al. Expression profiling of esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: clinical implications. Int J Oncol 2006; 28: 1345-52.
27. Aravind L, Koonin EV. The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases. Genome Biol 2001; 2: 1-8.
28. Isgro TA, Schulten K. Association of nuclear pore FG-repeat domains to NTF2 import and export complexes. J Mol Biol 2007; 366: 330-45.
29. Makhnevych T, Lusk CP, Anderson AM, Aitchison JD, Wozniak RW. Cell cycle regulated transport controlled by alterations in the nuclear pore complex. Cell 2003; 115: 813-23.
30. Chen D, Zhang J, Li M, Rayburn ER, Wang H, Zhang R. RYBP stabilizes p53 by modulating MDM2. EMBO Rep 2009; 10: 166-72.